Report overview
Human papilloma virus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available vaccines protect against either two, four, or nine types of HPV. All vaccines protect against at least HPV type 16 and 18 that cause the greatest risk of cervical cancer. It is estimated that they may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and possibly some mouth cancer. They additionally prevent some genital warts with the vaccines against 4 and 9 HPV types providing greater protection.
This report aims to provide a comprehensive presentation of the global market for HPV Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HPV Vaccines. This report contains market size and forecasts of HPV Vaccines in global, including the following market information:
Global HPV Vaccines Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global HPV Vaccines Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five HPV Vaccines companies in 2022 (%)
The global HPV Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
HPV vaccine is an inactivated (not live) vaccine which protects against four major types of HPV. These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Human papillomaviruses (HPVs) are a group of more than 200 related viruses. More than 40 HPV types can be easily spread through direct sexual contact, from the skin and mucous membranes of infected people to the skin and mucous membranes of their partners. They can be spread by vaginal, anal, and oral sex (1). Other HPV types are responsible for non-genital warts, which are not sexually transmitted. The segment of Female HPV vaccine market witnessed growth at a noteworthy rate over the past few years and is expected to grow in the forecast period on the back of rising awareness regarding HPV related fatal diseases, rising healthcare expenditures along with rising disposable incomes. North America and Europe accounts for the maximum market share of the global HPV vaccines market and is expected to grow at highest CAGR during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the HPV Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HPV Vaccines Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global HPV Vaccines Market Segment Percentages, by Type, 2022 (%)
Adolescents
Adults
Global HPV Vaccines Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global HPV Vaccines Market Segment Percentages, by Application, 2022 (%)
Male
Female
Global HPV Vaccines Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global HPV Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies HPV Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies HPV Vaccines revenues share in global market, 2022 (%)
Key companies HPV Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies HPV Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute
Outline of Major Chapters:
Chapter 1: Introduces the definition of HPV Vaccines, market overview.
Chapter 2: Global HPV Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of HPV Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of HPV Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global HPV Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
